The expression of two key genes of lovastatin (LOV) biosynthesis has been studied in two Aspergillus terreus strains characterized by a more than hundredfold difference in the LOV yield. As compared to the wild-type strain ATCC 20542, in the overproducing strain 43-16 significantly enhanced expression level of LOV biosynthetic genes (by 5–50 times), transcription factor lovE (by 3–20 times), and the acs gene, which encodes acetyl-CoA synthetase (by two times), was detected. To improve the efficiency of LOV biosynthesis, recombinant A. terreus strains constitutively expressing the ACS1 gene from Saccharomyce scerevisiae or the lovE gene from A. terreus have been designed by metabolic engineering methods. According to the obtained results, the expression of ACS1 in strain 43-16 results in the suppression of lovC and lovD production and a more than 25% reduction of LOV production. In the case of low-active ATCC 20542/ACS1 recombinants, the expression level of lov genes remains almost unchanged, while the expression of the endogenous asc1 gene is enhanced and the LOV yield increases by 117%. Constitutive overexpression of the lovE gene in the ATCC 20452 strain results in the increase of mRNA levels of biosynthetic lov-genes and is accompanied by a significant (6–10 times) increase in the LOV yield.
Applied Biochemistry and Microbiology – Springer Journals
Published: Mar 13, 2018
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera